P/E ratio for Trinity Biotech (TRIB)
P/E ratio as of May 2024 (TTM): -2.17
According to Trinity Biotech 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.16584. At the end of 2022 the company had a P/E ratio of -0.7710.
P/E ratio history for Trinity Biotech from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.7710 | -102.29% |
| 2021 | 33.7 | -369.46% |
| 2020 | -12.5 | 1586.44% |
| 2019 | -0.7422 | -65.74% |
| 2018 | -2.17 | -18.82% |
| 2017 | -2.67 | 70.5% |
| 2016 | -1.57 | -112.46% |
| 2015 | 12.6 | -45.75% |
| 2014 | 23.2 | -59.28% |
| 2013 | 56.9 | 226.99% |
| 2012 | 17.4 | 26.31% |
| 2011 | 13.8 | 344.26% |
| 2010 | 3.10 | -57.03% |
| 2009 | 7.21 | -1573.52% |
| 2008 | -0.4896 | -90.55% |
| 2007 | -5.18 | -112.33% |
| 2006 | 42.0 | 202.72% |
| 2005 | 13.9 | 86.22% |
| 2004 | 7.45 | -31.46% |
| 2003 | 10.9 | 286.59% |
| 2002 | 2.81 | -77.06% |
| 2001 | 12.3 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 35.8 | -1,751.16% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 37.5 | -1,830.65% | 🇺🇸 USA |
 Danaher DHR | 30.8 | -1,521.36% | 🇺🇸 USA |
 QuidelOrtho QDEL | 198 | -9,260.42% | 🇺🇸 USA |
 OraSure Technologies OSUR | 9.19 | -524.30% | 🇺🇸 USA |
 Chembio Diagnostics CEMI | -0.3792 | -82.49% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -47.9 | 2,112.19% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.